SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,042,665 | +6.5% | 50,664 | +143.3% | 0.01% | -16.7% |
| Q2 2023 | $979,097 | +74412.7% | 20,823 | -33.5% | 0.01% | -40.0% |
| Q1 2023 | $1,314 | -99.8% | 31,323 | +82.0% | 0.02% | +33.3% |
| Q3 2022 | $674,000 | -43.8% | 17,207 | -53.7% | 0.02% | -51.6% |
| Q2 2022 | $1,200,000 | +178.4% | 37,165 | +646.6% | 0.03% | +158.3% |
| Q4 2020 | $431,000 | +98.6% | 4,978 | -4.4% | 0.01% | +9.1% |
| Q2 2020 | $217,000 | -63.2% | 5,207 | -36.2% | 0.01% | -57.7% |
| Q4 2019 | $590,000 | -29.4% | 8,166 | +52.9% | 0.03% | -10.3% |
| Q2 2018 | $836,000 | +260.3% | 5,341 | +279.3% | 0.03% | +383.3% |
| Q4 2017 | $232,000 | -22.7% | 1,408 | -70.8% | 0.01% | -25.0% |
| Q3 2017 | $300,000 | +27.7% | 4,815 | +62.9% | 0.01% | +14.3% |
| Q2 2017 | $235,000 | -66.9% | 2,955 | -80.9% | 0.01% | -58.8% |
| Q3 2016 | $711,000 | +152.1% | 15,449 | +64.8% | 0.02% | +183.3% |
| Q2 2016 | $282,000 | +23.1% | 9,373 | +199.4% | 0.01% | -14.3% |
| Q2 2015 | $229,000 | – | 3,131 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |